Bachem has shocked the pharmaceutical industry with its massive $2.3 billion acquisition of AmWiner, marking one of the largest deals in the peptide therapeutics sector this year. This strategic takeover signals https://zoyasqpx880971.bcbloggers.com/36176051/breaking-usa-bachem-corporation-acquires-amwiner-in-2-3-billion-pharma-deal